A detailed history of Beacon Pointe Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 20,909 shares of BSX stock, worth $1.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
20,909
Previous 22,036 5.11%
Holding current value
$1.82 Million
Previous $1.7 Million 3.3%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $82,225 - $94,668
-1,127 Reduced 5.11%
20,909 $1.75 Million
Q2 2024

Aug 12, 2024

SELL
$67.33 - $77.71 $36,492 - $42,118
-542 Reduced 2.4%
22,036 $1.7 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $53,568 - $63,816
930 Added 4.3%
22,578 $1.55 Million
Q4 2023

Feb 08, 2024

SELL
$48.64 - $57.81 $34,193 - $40,640
-703 Reduced 3.15%
21,648 $1.25 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $464,909 - $506,500
9,263 Added 70.77%
22,351 $1.18 Million
Q2 2023

Aug 11, 2023

SELL
$49.72 - $54.64 $99,688 - $109,553
-2,005 Reduced 13.28%
13,088 $707,000
Q1 2023

May 12, 2023

BUY
$45.09 - $50.03 $11,272 - $12,507
250 Added 1.68%
15,093 $755,000
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $70,614 - $84,287
1,785 Added 13.67%
14,843 $686,000
Q3 2022

Nov 09, 2022

BUY
$36.71 - $109.66 $9,324 - $27,853
254 Added 1.98%
13,058 $500,000
Q2 2022

Aug 11, 2022

SELL
$35.24 - $47.1 $265,991 - $355,510
-7,548 Reduced 37.09%
12,804 $478,000
Q1 2022

May 17, 2022

BUY
$40.9 - $45.1 $495,421 - $546,296
12,113 Added 147.02%
20,352 $901,000
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $13,629 - $16,063
358 Added 4.54%
8,239 $350,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $10,637 - $11,837
258 Added 3.38%
7,881 $342,000
Q2 2021

Aug 17, 2021

BUY
$38.58 - $44.24 $294,095 - $337,241
7,623 New
7,623 $326,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.